Notably, MEG3 expression was significantly correlated with the prognosis of a total of nine types of cancers, including bladder cancer, brain cancer, breast cancer, head and neck cancer, blood cancer, colorectal cancer, eye cancer, lung cancer, and ovarian cancer. The gene discussed is MEG3; the disease is hematopoietic and lymphoid system neoplasm.